BioSpace News Archive

Genetown

Inozyme Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference

Inozyme Pharma, Inc. today announced Axel Bolte, MSc, MBA, the company’s co-founder, president, and chief executive officer, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13th at 8:45 AM ET.

April 6, 2022
·
1 min read
Biotech Beach

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Apr 06, 2022

Arrowhead Pharmaceuticals, Inc. announced that as an inducement to entering into employment with the Company, on April 1, 2022, the Compensation Committee of the Company’s Board of Directors approved “inducement” grants to 23 new employees under Rule 5635 of the NASDAQ Listing Rules.

April 6, 2022
·
1 min read
Biotech Bay

CareDx to Host Symposium at CEoT Featuring the Latest Multimodality Innovations in Kidney and Lung Transplant Surveillance

CareDx, Inc. today announced it will host the symposium, “Improved Precision with a Multimodality Approach,” during the annual American Society of Transplantation Cutting Edge of Transplantation.

April 6, 2022
·
4 min read
Biotech Bay

ASLAN Pharmaceuticals to Present at the Annual Needham Virtual Healthcare Conference 2022

ASLAN Pharmaceuticals today announced that Dr Carl Firth, CEO, will present at the 21st Annual Needham Virtual Healthcare Conference.

April 6, 2022
·
1 min read
PolyPid Secures $15 Million Non-Dilutive Secured Term Loan Facility

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that the Company has entered into a secured loan agreement for up to $15 million with Kreos Capital VI LP.

April 6, 2022
·
7 min read
BioMidwest

BioVigil Raises Growth Funding Round to Accelerate Success

BioVigil has raised growth funding to accelerate success and scale the business.

April 6, 2022
·
2 min read
Business

Nevro to Report First Quarter 2022 Financial Results

Company to Host Conference Call on Wednesday, May 4, 2022 at 1:30 pm PT / 4:30 pm ET.

April 6, 2022
·
2 min read
Business

Oncolytics Biotech® Letter to Shareholders - Update on Recent Progress

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) is providing a letter to shareholders.

April 6, 2022
·
13 min read
Genetown

Epizyme Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 06, 2022

Epizyme announced that the Company has granted equity awards to Jerald Korn, the Company’s Chief Operating Officer, with a grant date of April 1, 2022, as equity inducement awards outside of the Company’s 2013 Stock Incentive Plan and material to Mr. Korn’s acceptance of employment with the Company.

April 6, 2022
·
1 min read
Genetown

AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Apr 06, 2022

AVROBIO, Inc. announced that the company has granted a non-statutory stock option for the purchase of up to 22,000 shares of the company’s common stock to one employee as an inducement award under the company’s 2019 Inducement Plan.

April 6, 2022
·
5 min read